The downregulation of miRNA-145 activates the Fli1/MCP-1 pathway, thus increasing the recruitment of MDMs and shaping the pro-inflammatory immune microenvironment in the liver, exacerbating liver fibrosis [196]. Here, CCL2 is linked to Hepatic fibrosis.